NCT05758558

Brief Summary

Post COVID-19 usually occurs 3 months from the onset of COVID-19 with symptoms that last for at least 2 months and cannot be explained by an alternative diagnosis. Patients report a range of disabling symptoms such as fatigue, shortness of breath, cognitive impairment, memory loss and mental health and employment issues. This clinical heterogeneity complicates the identification of the appropriate needs and care. The aim of this cross-sectional study is to identify subgroups (clusters) of post COVID patients based on clinical symptoms, demographic characteristics, levels of fatigue and physical, cognitive and psychological functioning of the individuals.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
69

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started May 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 8, 2023

Completed
27 days until next milestone

First Posted

Study publicly available on registry

March 7, 2023

Completed
2 months until next milestone

Study Start

First participant enrolled

May 5, 2023

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2024

Completed
Last Updated

February 12, 2026

Status Verified

February 1, 2026

Enrollment Period

1.1 years

First QC Date

February 8, 2023

Last Update Submit

February 10, 2026

Conditions

Outcome Measures

Primary Outcomes (4)

  • Physical evaluation

    Hand grip strength (Jamar hand dynamometer) \& Six Minute Walk Test (6MWT)

    Day 1

  • Fatigue severity

    Fatigue severity scale (FSS)

    Day 1

  • Psychological evaluation

    Anxiety and depression Scale (HADS); MINI-S, MINI International Neuropsychiatric Interview - Simplified (Overbeek \& Schruers 2019)

    Day 1

  • Cognitive evaluation

    Multi-modal Evaluation of Sensory Sensitivity (MESSY); Montreal Cognitive Assessment (MoCA)

    Day 1

Other Outcomes (1)

  • Number of clusters

    Day 1

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Participants that match the criteria of the recently published definition of the post-COVID-19 condition will be considered eligible to participate in the study.\[8\] Post-COVID-19 has been defined as a condition that occurs in individuals with a history of confirmed SARS-CoV-2 infection, and that occurs usually within three months from the onset of COVID-19 with symptoms that last for at least two months and cannot be explained by an alternative diagnosis. Consequently, participants that either have or have not been hospitalized will both be allowed to participate in this study. COVID infection will be self-reported by the participant. Participants will be encouraged to show any test certificate but they are not obligated to do so.

You may qualify if:

  • The participant must report current persisting symptoms (such as brain fog, anxiety, shortness of breath, headaches but also others) and indicate on the Post COVID-19 Functional Status Scale that these have an impact on everyday functioning (grade 2, 3, and 4). These symptoms need to be present for more than two months.
  • Fatigue Severity Scale (FSS) score \> 4
  • Aged over 18 years old
  • Willing to sign the digital informed consent
  • Dutch speaking and Dutch understanding
  • Be tested positive for COVID-19, i.e. by reverse transcription polymerase chain reaction (RT-PCR), computed tomography (CT) of the lungs, or symptom-based diagnosis by the general practitioner.

You may not qualify if:

  • Pregnant women
  • Pacemaker, defibrillator
  • Brain or nerve disorders
  • Epilepsy
  • A copper spiral or recent bone fracture

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hasselt University

Diepenbeek, 3590, Belgium

Location

MeSH Terms

Conditions

Post-Acute COVID-19 Syndrome

Condition Hierarchy (Ancestors)

COVID-19Pneumonia, ViralPneumoniaRespiratory Tract InfectionsInfectionsVirus DiseasesCoronavirus InfectionsCoronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsLung DiseasesRespiratory Tract DiseasesPost-Infectious DisordersChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Doctoral Assistant

Study Record Dates

First Submitted

February 8, 2023

First Posted

March 7, 2023

Study Start

May 5, 2023

Primary Completion

June 1, 2024

Study Completion

June 1, 2024

Last Updated

February 12, 2026

Record last verified: 2026-02

Locations